Programs

HomePrograms ▶ Partner Grants
Partner Grants

Important Notes

Applicants are strongly advised to read the instructions and eligibility criteria before starting an application.
Letters of Intent (LOI) are available on the Foundant Technologies Website.
You must be invited to submit a full application.


Anticipated Timeline

July 19, 2022 Letter of Intent Period Opens
September 26, 2022 Deadline for Letter of Intent due by 11:59 pm Eastern Time
November 2022 Invitation from Scientific Grant Review Committee for Full Applications
January 10, 2023 Full Application Deadline due by 11:59 pm Eastern Time
March 2023 Grantee Notification
April/May 2023 Grant Start Date

 

Partner Grant Opportunities

acda logo

*This grant no longer requires a Letter of Intent and has moved to this page


ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant

1 grant available
$25,000 per year for 2 years

Co-funded by the ACDA and The David Ashwell Foundation.

The ACDA and The David Ashwell Foundation are respectively USA- and UK-based not for profit charitable organizations founded by parents of infants with ACDMPV.  Funds are raised by parents, families, and friends globally with the aim of increasing scientific knowledge about ACDMPV and therapeutic strategies related thereto.

csl behring logo

ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome (ARDS)
1 grant available
$50,000 per year for 1 year

Target Audience:
Early-stage investigators interested in research on ARDS

The focus of this research grant is proposals that advance understanding of acute respiratory distress syndrome (ARDS). Applicants may request up to $50,000 for 1 year. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Early-stage investigators (as defined here) 
• Must meet eligibility requirements for all grants found here

Fully funded by CSL Behring.

 

Fisher & Paykel

*This grant no longer requires a Letter of Intent and has moved to this page

ATS/Fisher & Paykel Healthcare Research Grant in Nasal High Flow
1 grant available
$50,000 per year for 2 years

Fully funded by Fisher & Paykel Healthcare.


Review Process

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Grant Review Committee (SGRC)* will review the applications at the end of February 2023. The membership of the SGRC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.

*previously known as the Scientific Advisory Committee (SAC)


ATS Policy on Additional Grant Funding

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SGRC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.


If your question is not answered in the FAQ, contact the Research Program at researchprogram@thoracic.org.

 

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.